MedTrace Logo

Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation

NCT03904485 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-04-05

No results posted yet for this study

Summary

Diabetic cardiomyopathy( DCM) is a major complication of diabetes and is a common cardiovascular complication independent of coronary artery disease and hypertension．Trial to assess of myocardial injury in recipients of simultaneous pancreas and kidney transplantation by nuclear magnetic T２ mapping technology.

Conditions

  • Simultaneous Pancreas-kidney Transplantation
  • Diabetic Cardiomyopathy

Interventions

RADIATION

cardiac magnetic resonance(CMR) T2 mapping

T2 value before transplant，3 month and 6month after transplant

Sponsors & Collaborators

  • Tianjin First Central Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-04-01
Completion
2021-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03904485 on ClinicalTrials.gov